semaglutide & tirzepatide gaithersburg GI and Hepatology News Semaglutide vs. Tirzepatide: Which GLP-1

With evidence that Ozempic can induce weight loss in people with obesity, even those without diabetes, in 2021, the FDA approved a higher-dose version of Ozempic, sold under the brand name Wegovy , to treat obesity and for weight management

Insulin Resistance Many patients develop insulin resistance, making it harder to regulate blood sugar and encouraging fat storage

Truncated glucagon-like peptide 1, an insulin-releasing hormone from the distal gut

Digestive side effects Symptoms such as nausea, bloating, or constipation are common and can affect appetite, food choices, and consistency

GLP-1 medications accelerate fat loss, but the skin does not tighten at the same pace